择期冠状动脉介入治疗临床护理路径的建立及其效果  

Establishment and Effect of Clinical Nursing Pathway of Elective Percutaneous Coronary Intervention in Patients with Coronary Artery Disease

作　　者：刘慧凤[1] 王志萍[2] 王红萍[1] 傅雪[1] 鞠蓓蓓[1] 王怡华[1] 

机构地区：[1]上海交通大学医学院附属新华医院心内科,上海200092 [2]上海医药高等专科学校护理系

出　　处：《解放军护理杂志》2010年第19期1458-1460,共3页Nursing Journal of Chinese People's Liberation Army

基　　金：上海医药高等专科学校上海护理研究中心科研基金项目(SNRC-08014)

摘　　要：目的建立择期冠状动脉介入治疗(percutaneous coronary intervention,PCI)临床护理路径,并探讨其在冠状动脉粥样硬化性心脏病介入治疗中的应用效果。方法组建临床路径小组,制定择期PCI临床路径及相关指标。将2009年1-7月行择期PCI的稳定型心绞痛患者250例随机分成实验组和对照组,对照组患者按常规进行护理,实验组患者根据临床路径表进行护理,比较两组患者的并发症发生情况、住院时间及医疗费用、患者满意度等。结果两组患者术后并发症的发生率差异无统计学意义(P>0.05),实验组患者平均住院日和平均住院费用明显低于对照组(P<0.05),患者满意度高于对照组(P<0.05)。结论临床护理路径的应用可缩短择期PCI患者的住院天数,降低医疗费用,强化对患者及家属的健康教育,提高患者满意率及医疗护理质量。Objective To establish a clinical nursing pathway of elective percutaneous coronary intervention（PCI） for patients with coronary artery disease and study the effects of it.Methods A specialist team was founded to form the clinical nursing pathway for elective PCI and its clinical criteria.From January to July 2009,250 patients diagnosed with stable angina were randomly distributed into an experimental group and a control group.The control group used the routine treatment and nursing,while the experimental group received the treatment and nursing according to the clinical nursing pathway.Comparisons were conducted on the differences in complications,hospital stay and medical costs and patient satisfaction of the two groups.Results There was no significant difference in the rate of complications in the two groups（P〈0.05）.However,the number of hospitalization days and the average medical cost were significantly less than those in the experimental group（P〈0.05）.Moreover,the satisfaction in the experimental group was superior to that in the control group（P〈0.05）.Conclusion The establishment of clinical nursing pathway can reduce the cost and length of hospitalization,enhance health education,and promote patients’ satisfaction and nursing quality.

关 键 词：临床护理路径 介入治疗 冠状动脉粥样硬化性心脏病 

分 类 号：R815[医药卫生—放射医学] R197.323[医药卫生—临床医学]